We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+1.78%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$3.85B
AUM Growth
-$284M
Cap. Flow
-$132M
Cap. Flow %
-3.43%
Top 10 Hldgs %
21.54%
Holding
5,768
New
656
Increased
2,740
Reduced
1,651
Closed
687

Sector Composition

Rank Sector Weight
1 Technology 21.48%
2 Financials 7.64%
3 Healthcare 7.18%
4 Consumer Discretionary 6.43%
5 Industrials 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COYA icon
4176
Coya Therapeutics
COYA
$98.3M
$4.66K ﹤0.01%
+1,182
New +$5.53K
MINT icon
4177
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$16.9B
$4.63K ﹤0.01%
46
-44
-49% -$4.42K
UUUG
4178
Leverage Shares 2X Long UUUU Daily ETF
UUUG
$8.88M
$4.63K ﹤0.01%
+449
New +$7.03K
AMOD
4179
Alpha Modus Holdings
AMOD
$19.2M
$4.62K ﹤0.01%
314
+301
+2,315% +$7.43K
PAA icon
4180
Plains All American Pipeline
PAA
$17.3B
$4.6K ﹤0.01%
206
-941
-82% -$19.1K
ZYBT
4181
Zhengye Biotechnology Holding
ZYBT
$63M
$4.59K ﹤0.01%
4,912
+2,705
+123% +$2.53K
TPST icon
4182
Tempest Therapeutics
TPST
$13.7M
$4.58K ﹤0.01%
2,790
+1,465
+111% +$3.54K
CLIR icon
4183
ClearSign Technologies
CLIR
$24.3M
$4.56K ﹤0.01%
1,045
-335
-24% -$1.92K
WVVI icon
4184
Willamette Valley Vineyards
WVVI
$12.7M
$4.55K ﹤0.01%
1,771
+463
+35% +$1.26K
ATOS icon
4185
Atossa Therapeutics
ATOS
$20.6M
$4.54K ﹤0.01%
863
+596
+223% +$3.77K
BBLG
4186
Bone Biologics
BBLG
$1.53M
$4.54K ﹤0.01%
4,126
+747
+22% +$1.03K
HHS icon
4187
Harte-Hanks
HHS
$16.2M
$4.53K ﹤0.01%
1,995
+857
+75% +$2.43K
VRCA icon
4188
Verrica Pharmaceuticals
VRCA
$89.7M
$4.53K ﹤0.01%
856
-2,486
-74% -$15.9K
TCRT icon
4189
Alaunos Therapeutics
TCRT
$4.59M
$4.53K ﹤0.01%
1,583
+502
+46% +$1.5K
TAN icon
4190
Invesco Solar ETF
TAN
$1.42B
$4.51K ﹤0.01%
81
-435
-84% -$24.1K
OXBR icon
4191
Oxbridge Re Holdings
OXBR
$10.6M
$4.5K ﹤0.01%
3,817
+830
+28% +$898
VRME icon
4192
VerifyMe
VRME
$9.38M
$4.5K ﹤0.01%
5,557
-378
-6% -$385
LVLU icon
4193
Lulu's Fashion Lounge
LVLU
$46.6M
$4.49K ﹤0.01%
353
-468
-57% -$6.92K
FLNT
4194
Fluent
FLNT
$102M
$4.48K ﹤0.01%
1,418
+4
+0.3% +$13
CATO icon
4195
Cato Corp
CATO
$68.3M
$4.47K ﹤0.01%
1,581
+683
+76% +$2.1K
BYFC icon
4196
Broadway Financial
BYFC
$93.8M
$4.47K ﹤0.01%
616
-5
-0.8% -$40
GOVT icon
4197
iShares US Treasury Bond ETF
GOVT
$43.6B
$4.47K ﹤0.01%
+195
New +$4.5K
GLAD icon
4198
Gladstone Capital
GLAD
$422M
$4.44K ﹤0.01%
256
-75
-23% -$1.43K
RDNW
4199
RideNow Group
RDNW
$238M
$4.42K ﹤0.01%
+626
New +$3.79K
BOLT icon
4200
Bolt Biotherapeutics
BOLT
$7.67M
$4.42K ﹤0.01%
1,093
+370
+51% +$1.93K

Similar funds

Tower Research Capital (TRC)'s Q1 2026 Portfolio in Review

As of Q1 2026, Tower Research Capital (TRC) held 5,768 positions worth $3.85B, down 6.9% from $4.13B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Tower Research Capital (TRC) withdrew a net $132M in Q1 2026, closing 687 positions and reducing 1,651 holdings. Its most notable exit was State Street SPDR Bloomberg Short Term High Yield Bond ETF, an estimated $58.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core US Aggregate Bond ETF worth $39.7M.

  • Tower Research Capital (TRC)'s largest Q1 2026 buy was iShares Core US Aggregate Bond ETF: 400,371 shares worth $39.7M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q1 2026, an estimated $147M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2026 reduction was NVIDIA, cutting an estimated $104M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Bloomberg Short Term High Yield Bond ETF in Q1 2026, selling an estimated $58.1M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 22% of its $3.85B portfolio in Q1 2026.
  • Tower Research Capital (TRC) opened 656 new positions and closed 687 in Q1 2026.
  • Tower Research Capital (TRC)'s portfolio value fell 6.9% quarter-over-quarter to $3.85B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.